413 related articles for article (PubMed ID: 23526637)
1. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.
Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637
[TBL] [Abstract][Full Text] [Related]
2. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F
PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330
[TBL] [Abstract][Full Text] [Related]
3. Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells.
Honegger A; Schilling D; Sültmann H; Hoppe-Seyler K; Hoppe-Seyler F
Methods Mol Biol; 2018; 1699():119-134. PubMed ID: 29086374
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
Inturi R; Jemth P
Virology; 2021 Oct; 562():92-102. PubMed ID: 34280810
[TBL] [Abstract][Full Text] [Related]
9. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
10. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS
BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929
[TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
[TBL] [Abstract][Full Text] [Related]
13. Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses.
Kuner R; Vogt M; Sultmann H; Buness A; Dymalla S; Bulkescher J; Fellmann M; Butz K; Poustka A; Hoppe-Seyler F
J Mol Med (Berl); 2007 Nov; 85(11):1253-62. PubMed ID: 17589817
[TBL] [Abstract][Full Text] [Related]
14. Brg1 regulates the transcription of human papillomavirus type 18 E6 and E7 genes.
He H; Luo Y
Cell Cycle; 2012 Feb; 11(3):617-27. PubMed ID: 22262178
[TBL] [Abstract][Full Text] [Related]
15. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression.
Borbély ÁA; Murvai M; Kónya J; Beck Z; Gergely L; Li F; Veress G
J Gen Virol; 2006 Feb; 87(Pt 2):287-294. PubMed ID: 16432013
[TBL] [Abstract][Full Text] [Related]
16. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.
Tang S; Tao M; McCoy JP; Zheng ZM
J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884
[TBL] [Abstract][Full Text] [Related]
17. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
18. Effect of simultaneous silencing of HPV-18 E6 and E7 on inducing apoptosis in HeLa cells.
Qi Z; Xu X; Zhang B; Li Y; Liu J; Chen S; Chen G; Huo X
Biochem Cell Biol; 2010 Aug; 88(4):697-704. PubMed ID: 20651842
[TBL] [Abstract][Full Text] [Related]
19. Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.
Tan CL; Teissier S; Gunaratne J; Quek LS; Bellanger S
Cell Cycle; 2015; 14(9):1459-70. PubMed ID: 25789401
[TBL] [Abstract][Full Text] [Related]
20. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
